Wednesday, November 25, 2009, 2:59am EST - Canadian Markets open in 6 hours and 31 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Viral Genetics Inc. (VRAL.PK)

 On Nov 24: 0.054 USD  Down 0.001 (1.82%)  
MORE ON VRAL.PK
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
VIRAL GENETICS INC (Other OTC:VRAL.PK) Delayed quote dataEdit
Last Trade: 0.054 USD
Trade Time: Nov 24
Change: Down 0.001 (1.82%)
Prev Close: 0.055
Open: 0.053
Bid: N/A
Ask: N/A
1y Target Est: 0.20
Day's Range: 0.053 - 0.055
52wk Range: 0.01 - 0.13
Volume: 278,202
Avg Vol (3m): 2,098,570
Market Cap: 19.84M
P/E (ttm): N/A
EPS (ttm): -0.032
Div & Yield: N/A (N/A%)
Viral Genetics Inc. (VRAL.PK)
1d  5d  3m  6m  1y  2y  5y  max 
 Add VRAL.PK to Portfolio   Download Data

HEADLINES
• Viral Genetics' Lead Scientist Dr. M. Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference
PRNewswire (Wed, Sep 16)
• Viral Genetics Completes Second Major Debt Conversion
PRNewswire (Wed, Aug 26)
• Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases
PRNewswire (Wed, Aug 26)
• VIRAL GENETICS INC /DE/ Files SEC form 8-K, Unregistered Sale of Equity Securities
EDGAR Online (Tue, Feb 17)
• VIRAL GENETICS INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 18)
More Headlines for VRAL.PK...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: N/A
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Viral Genetics, Inc. engages in the research and development of protein-based therapeutic and diagnostic products with applications in infectious disease, autoimmune conditions, and immunological deficiency.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices